CD8A and COVID-19: SARS-CoV-2-infected PBMC from COVID-19 presented a significantly higher expression of genes related to virus entry (cellular SARS-CoV-2 receptor ACE2) and apoptosis (CARD6, and CARD9); reinforcing CD8+ T cells CD95+ immunophenotyping (Figure 6a,b).